This is pretty interesting in the fact that the device mixes silver, zinc and copper ions within the device instead of a coating placed on the outside, in other words it is part of the product or solution.  5 percent of spinal surgeries are known to involve infections and this appears to be able to fight imageoff the bacteria after surgery, it is not FDA approved yet but anticipated later this year.  The company is currently existing on “Angel” funding, of which, most investors are surgeons. 

With the never-never events scrutinized at hospitals, this looks like it could have some real benefit in reducing the number of infections after surgery.  BD 

DiFusion Technologies Inc., a start-up medical device company, is gearing up to launch a flagship product that will target the orthopedic market at the same time it's raising additional capital.

Dr. Matthew Geck, founder and board member of DiFusion, said the company will release a medical device this year capable of killing 650 types of bacteria, including antibiotic-resistant bacteria such as MRSA (also known as “Superbugs”), in local surgical wounds for up to four weeks following surgery.

 image

DiFusion Technologies takes aim at surgical infections - Austin Business Journal:

1 comments :

  1. This could be a huge savings to hospitals performing spine surgery

    ReplyDelete

 
Top
Google Analytics Alternative